LRP4 antibody testing in myasthenia gravis

J Neuroimmunol. 2022 Oct 15:371:577949. doi: 10.1016/j.jneuroim.2022.577949. Epub 2022 Aug 12.

Authors

Michael K Racke¹, Sat Dev Batish², Robert P Lisak³, Richard J Barohn⁴

Affiliations

¹ Quest Diagnostics, 500 Plaza Drive, Secaucus, NJ 07094, USA. Electronic address: Michael.K.Racke@QuestDiagnostics.com.
² Athena Diagnostics, Marlborough, MA, USA.
³ Department of Neurology, Wayne State University and Detroit Medical Center, Detroit, MI, USA.
⁴ Department of Neurology, School of Medicine, University of Missouri, Columbia, MO, USA.

PMID: 35973344
DOI: 10.1016/j.jneuroim.2022.577949

No abstract available

Publication types

Letter
Comment

MeSH terms

Autoantibodies
Humans
LDL-Receptor Related Proteins
Myasthenia Gravis* / diagnosis
Receptors, Cholinergic

Substances

Autoantibodies
LDL-Receptor Related Proteins
LRP4 protein, human
Receptors, Cholinergic